(Q42457448)

31 October 2017

Pharmacological characterization of the human melatonin Mel1a receptor following stable transfection into NIH3T3 cells (English)

1 reference

31 October 2017

0 references

Nonno R

1

1 reference

31 October 2017

Lucini V

2

1 reference

31 October 2017

Pannacci M

3

1 reference

31 October 2017

Mazzucchelli C

4

1 reference

31 October 2017

Angeloni D

5

1 reference

31 October 2017

Fraschini F

6

1 reference

31 October 2017

Stankov BM

7

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Pharmacology

31 October 2017

1 reference

31 October 2017

124

1 reference

31 October 2017

3

1 reference

31 October 2017

485-492

1 reference

Receptor-effector coupling by G proteins

31 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

Evidence for multiple forms of melatonin receptor-G-protein complexes by solubilization and gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

The adult human cerebellum is a target of the neuroendocrine system involved in the circadian timing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Serotonin and N-acetylserotonin effects on pigment cells of the toad Bufo ictericus: pharmacological characterization of melatonin receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Melatonin comes of age?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Analysis of competitive agonist-antagonist interactions by nonlinear regression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

The melatonin receptor in the human brain: cloning experiments and distribution studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Melatonin receptors: localization, molecular pharmacology and physiological significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

2-[125I]iodomelatonin binding sites in the bovine hippocampus are not sensitive to guanine nucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Characterization and mapping of melatonin receptors in the brain of three mammalian species: rabbit, horse and sheep. A comparative in vitro binding study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Efficacy. I: A new method for estimating relative efficacy of full agonists via a newly defined efficacy related parameter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701860

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701860

1 reference

31 October 2017

1 reference

31 October 2017

PubMed publication ID

9647472

1 reference